Pernock David 4
4 · EAGLE PHARMACEUTICALS, INC. · Filed Jan 25, 2019
Insider Transaction Report
Form 4
Pernock David
Director
Transactions
- Tax Payment
Common Stock
2019-01-07$41.33/sh−858$35,461→ 10,108 total - Award
Common Stock
2019-01-23+20,900→ 31,008 total - Award
Employee Stock Option (right to buy)
2019-01-23+46,600→ 46,600 totalExercise: $42.40Exp: 2029-01-23→ Common Stock (46,600 underlying)
Footnotes (4)
- [F1]Represents shares withheld to satisfy withholding tax obligations.
- [F2]Represents restricted stock units ("RSUs"). The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the one, two, three and four-year anniversaries of January 23, 2019, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
- [F3]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F4]The option vests over a period of four years, with 25% of the shares underlying the option vesting on January 23, 2020, the first anniversary of the date of grant, and the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.